tiprankstipranks
Trending News
More News >
Hansa Biopharma (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Hansa Biopharma’s (HNSA) Moving Averages Convergence Divergence (MACD) indicator is -0.77, suggesting Hansa Biopharma is a Sell.
Hansa Biopharma’s (HNSA) 20-Day exponential moving average is 22.73, while Hansa Biopharma’s (HNSA) share price is kr22.4, making it a Sell.
Hansa Biopharma’s (HNSA) 50-Day exponential moving average is 24.75, while Hansa Biopharma’s (HNSA) share price is kr22.4, making it a Sell.

Hansa Biopharma AB (HNSA) Pivot Points

Apr 11, 2025, 11:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.85
22.27
22.63
23.05
23.41
23.83
24.19
Fibonacci
22.27
22.57
22.76
23.05
23.35
23.54
23.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hansa Biopharma AB (HNSA) Moving Averages

Apr 11, 2025, 11:37 PM
Period
Simple
Exponential
MA5
22.13Sell
22.26Sell
MA10
22.31Sell
22.38Sell
MA20
22.70Sell
22.73Sell
MA50
24.18Sell
24.75Sell
MA100
28.77Sell
28.10Sell
MA200
35.27Sell
32.91Sell
Hansa Biopharma’s (HNSA) 10-Day exponential moving average is 22.38, while Hansa Biopharma’s (HNSA) share price is kr22.4, making it a Sell.
Hansa Biopharma’s (HNSA) 100-Day exponential moving average is 28.10, while Hansa Biopharma’s (HNSA) share price is kr22.4, making it a Sell.
Hansa Biopharma’s (HNSA) stock price is kr22.4 and Hansa Biopharma’s (HNSA) 50-day simple moving average is 24.18, creating a Sell signal.
Hansa Biopharma’s (HNSA) stock price is kr22.4 and Hansa Biopharma’s (HNSA) 100-day simple moving average is 28.77, creating a Sell signal.
Hansa Biopharma’s (HNSA) stock price is kr22.4 and Hansa Biopharma’s (HNSA) 200-day simple moving average is 35.27, creating a Sell signal.

Hansa Biopharma AB (HNSA) Technical Indicators

Apr 11, 2025, 11:37 PM
Name
Value
Implied Action
RSI (14)
39.80
Neutral
STOCH (9,6)
39.25
Neutral
STOCHRSI (14)
49.44
Neutral
MACD (12,26)
-0.77
Sell
ADX (14)
19.34
Buy
Williams %R
-63.56
Buy
CCI (14)
-73.27
Neutral
ATR (14)
1.19
-
Ultimate Oscillator
45.85
Neutral
ROC
-6.27
Sell
Hansa Biopharma’s (HNSA) Relative Strength Index (RSI) is 39.80, creating a Neutral signal.
Hansa Biopharma’s (HNSA) Trend Strength Indicator (ADX) is 19.34, creating a Buy signal.
Hansa Biopharma’s (HNSA) Commodity Channel Index (CCI) is -73.27, creating a Neutral signal.
Hansa Biopharma’s (HNSA) Price Rate of Change (ROC) is -6.27, creating a Sell signal.

FAQ

Is HNSA a Buy, Hold, or Sell?
Based on HNSA’s technical indicators, HNSA is a Strong Sell.
    What is HNSA’s RSI (14)?
    HNSA’s RSI (14) is 39.80, which suggests HNSA is a Neutral.
      What is HNSA’s MACD?
      HNSA’s MACD is -0.77, which suggests HNSA is a Sell.
        What is HNSA’s 5-day moving average?
        HNSA’s 5-day moving average is 22.13, which suggests HNSA is a Sell.
          What is HNSA’s 20-day moving average?
          HNSA 20-day moving average is 22.70, which suggests HNSA is a Sell.
            What is HNSA’s 50-day moving average?
            HNSA’s 50-day moving average is 24.18, which suggests HNSA is a Sell.
              What is HNSA’s 200-day moving average?
              HNSA’s 200-day moving average is 35.27, which suggests HNSA is a Sell.
                What is HNSA’s Williams % R (14)?
                HNSA’s Williams % R (14) is -63.56, which suggests HNSA is a Buy.
                  What is HNSA’s CCI (14)?
                  HNSA’s CCI (14) is -73.27, which suggests HNSA is a Neutral.
                    What is the share price of Hansa Biopharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis